Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03391856
What this trial is testing

Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy

Who this might be right for
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital 15
Not applicableNot Yet RecruitingNCT07440654
What this trial is testing

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

Who this might be right for
aGVHD Prophylaxis
Nanfang Hospital, Southern Medical University 40
Not applicableStudy completedNCT06267898
What this trial is testing

Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML

Who this might be right for
MDSCMML
European Society for Blood and Marrow Transplantation 222
Large-scale testing (Phase 3)Study completedNCT01457040
What this trial is testing

Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaStem Cell Transplantation, Hematopoietic
Nanfang Hospital, Southern Medical University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT07232953
What this trial is testing

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia (AML)Hematopoietic Stem Cell Transplant (HSCT)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 82
Not applicableStudy completedNCT02064972
What this trial is testing

CEC Count Changes to Support GvHD Diagnosis.

Who this might be right for
Graft vs Host DiseaseComplications of Organ Transplant Stem CellsEndothelial Dysfunction
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 50
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Very early researchNot Yet RecruitingNCT07674199
What this trial is testing

EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT

Who this might be right for
Patients After Hematopoietic Stem Cell Transplantation
The General Hospital of Western Theater Command 20
Testing effectiveness (Phase 2)Study completedNCT01991457
What this trial is testing

Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia

Who this might be right for
Adult Lymphoblastic Lymphoma
University of Alabama at Birmingham 19
Not applicableNot Yet RecruitingNCT06386445
What this trial is testing

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

Who this might be right for
Stem Cell Transplant ComplicationsAcute Graft Versus Host DiseaseAcute Kidney Injury+1 more
First Affiliated Hospital Xi'an Jiaotong University 500
Large-scale testing (Phase 3)UnknownNCT03596892
What this trial is testing

Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationConditionsMixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia
Nanfang Hospital, Southern Medical University 122
Large-scale testing (Phase 3)UnknownNCT05453552
What this trial is testing

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 242
Post-approval studies (Phase 4)Looking for participantsNCT06571825
What this trial is testing

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Who this might be right for
Acute Myeloid Leukemia
He Huang 118
Not applicableStudy completedNCT04386928
What this trial is testing

ALLO-SCT in Elderly Patients With Hematological Disease

Who this might be right for
Hematologic DiseasesStem Cell Transplant Complications
Gruppo Italiano Trapianto di Midollo Osseo 1,996
Testing effectiveness (Phase 2)Study completedNCT00577278
What this trial is testing

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
City of Hope Medical Center 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT07199855
What this trial is testing

Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University 24
Not applicableLooking for participantsNCT07253129
What this trial is testing

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 88
Testing effectiveness (Phase 2)Looking for participantsNCT04959903
What this trial is testing

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Who this might be right for
Hematological Malignancies
Smart Immune SAS 36
Testing effectiveness (Phase 2)Looking for participantsNCT06872333
What this trial is testing

Allo HSCT for High Risk Hemoglobinopathies

Who this might be right for
Graft FailureSickle Cell DiseaseHemoglobinopathies
Masonic Cancer Center, University of Minnesota 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Next Page